Overview of epidemiological registries in Bulgaria

Tsonka Miteva-Katrandzhieva

Abstract


Background: Understanding the importance of collecting epidemiological data Bulgarian association for promotion of education and science was motivated to start an important initiative in 2008, namely tracing the way for establishing a rare disease epidemiological registry in Bulgaria. This initiative was in conformity with one of the basic aims of the Bulgarian National program for development in the field of rare diseases. Till now several private initiatives on rare diseases registries have been realized in the country resulting in excellent-working databases. This is a costless experience that could be shared in order to support the design, implementation, analysis, interpretation and quality evaluation.

Aim: The aim of this study was to provide up-to-date and reliable information on the epidemiological registries for rare diseases officially processing in Bulgaria.

Study design: The authors did a systematic review of the available data from the existing registries for rare diseases in the country.

Material and methods: For originating the rare diseases epidemiological registries report several sequential strategies were used. The inquiry contained the following summary indicators: 1) year of launch; 2) year of latest update; 3) number of patients from latest update; 4) distribution by sex; 5) distribution by age. Also the main features of rare diseases registries were described.

Results: Consent forms and date information were provided by 14 rare diseases registries.

Conclusion: The benefits of rare diseases registries are many and they stimulate all Bulgarian stakeholders to continue to give their best to support the management of the epidemiological rare diseases registries in the country.

Keywords


epidemiological registries; rare diseases; epidemiological data

Full Text:

PDF

References


Communication from the Commission to the European Parliament, the Council, the European economic and social committee and the Committee of the regions on Rare Diseases: Europe's challenges, http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf.

Council Recommendation (2009/C 151/02) on an action in the field of rare diseases, http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:EN:PDF.

European project for rare diseases national plan development (EUROPLAN). Recommendations for the development of national plans for rare diseases, http://www.europlanproject.eu/_newsite_986987/Resources/docs/2008-2011_2.EUROPLANGuidance.pdf.

Önal G, Civaner M. For What Reasons Do Patients File a Complaint? A Retrospective Study on Patient Rights Units’ Registries. Balkan Med J 2015; 32: 17-22. DOI:10.5152/balkanmedj.2015.15433.

Directive 2011/24/EU of the European Parliament and of the Council on the application of patients’ rights in cross-border healthcare, http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:088:0045:0065:EN:PDF

Posada de la Paz M, Groft S C (Eds.) Rare Diseases Epidemiology. Springer’s Advances in Experimental Medicine and Biology, Vol. 686; 2010.

EUCERD Recommendations on Rare Disease Patient Registration and Data Collection (5 June 2013), http://www.eucerd.eu/wpcontent/uploads/2013/06/EUCERD_Recommendations_RDRegistryDataCollection_adopted.pdf.

European Platform for Rare Disease Registries (EPIRARE), http://www.epirare.eu/

RD-CONNECT – an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research http://rd-connect.eu/.

Ministry of Health. National program for rare diseases (2009 – 2013), http://www.raredis.org/pub/events/NPRD.pdf.

2nd National conference for rare diseases and orphan drugs – conference proceedings book, 2011 (in Bulgarian), http://raredis.org/pub/Newsletter/Conference_Book_2011.pdf.

3rd National conference for rare diseases and orphan drugs – conference proceedings book, 2012 (in Bulgarian), http://raredis.org/pub/Newsletter/Conference_Book_2012_LQ.pdf.

4th National conference for rare diseases and orphan drugs – conference proceedings book, 2013 (in Bulgarian), http://raredis.org/pub/Newsletter/Book_2013_LQ.pdf.